Synopsis
Synopsis
0
KDMF
0
VMF
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
Annual Reports
NA
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Cellcristin
2. Citomid
3. Farmistin
4. Leurocristine
5. Oncovin
6. Oncovine
7. Onkocristin
8. Pfs, Vincasar
9. Sulfate, Vincristine
10. Vincasar
11. Vincasar Pfs
12. Vincristin Bristol
13. Vincristin Medac
14. Vincristine
15. Vincrisul
16. Vintec
1. 2068-78-2
2. Kyocristine
3. Vincristine Sulphate
4. Vincrisul
5. Leurocristine Sulfate
6. Oncovin
7. Onkovin
8. Marqibo
9. 22-oxovincaleukoblastine Sulfate
10. Vcr Sulfate
11. Rel-vincristine Sulfate
12. Nsc 67574
13. Lilly 37231
14. Nsc67574
15. Nsc-67574
16. Leurocristine, Sulfate (1:1) (salt)
17. Alkaloid Extracted From Vinca Rosea Linn
18. Novopharm
19. Chebi:79401
20. 1217704-93-2
21. Mls002702994
22. Lilly-37231
23. Vincristini Sulfas
24. Oncovin (lilly)
25. Vincasar (tn)
26. Marqibo (tn)
27. Oncovin (tn)
28. Vincrex (tn)
29. Vincristine, Sulfate
30. Leurocristine, Sulfate
31. Vincristine Sulphate Salt
32. Vincristine Sulfate Liposome
33. Schembl3710
34. Leurocristine Sulfate (1:1)
35. Chembl501867
36. Dtxsid8044331
37. Vincristine Sulfate (jp17/usp)
38. Hms3414l13
39. Hms3678l11
40. Mfcd08706469
41. Akos015895862
42. V0129
43. Lcr
44. Vcr
45. D02197
46. 068v782
47. A936684
48. Methyl (3ar,3a1r,4r,5s,5ar,10br)-4-acetoxy-3a-ethyl-9-((3s,5s,7s,9s)-5-ethyl-5-hydroxy-9-(methoxycarbonyl)-1,4,5,6,7,8,9,10-octahydro-2h-3,7-methano[1]azacycloundecino[5,4-b]indol-9-yl)-6-formyl-5-hydroxy-8-methoxy-3a,3a1,4,5,5a,6,11,12-octahydro-1h-indolizino[8,1-cd]carbazole-5-carboxylate Sulfate
Molecular Weight | 923.0 g/mol |
---|---|
Molecular Formula | C46H58N4O14S |
Hydrogen Bond Donor Count | 5 |
Hydrogen Bond Acceptor Count | 16 |
Rotatable Bond Count | 10 |
Exact Mass | 922.36702371 g/mol |
Monoisotopic Mass | 922.36702371 g/mol |
Topological Polar Surface Area | 254 Ų |
Heavy Atom Count | 65 |
Formal Charge | 0 |
Complexity | 1830 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 9 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 4 | |
---|---|
Drug Name | Marqibo kit |
Active Ingredient | Vincristine sulfate |
Dosage Form | Injectable, liposomal |
Route | Intravenous |
Strength | 5mg/5ml (1mg/ml) |
Market Status | Prescription |
Company | Talon Therap |
2 of 4 | |
---|---|
Drug Name | Vincristine sulfate pfs |
Active Ingredient | Vincristine sulfate |
Dosage Form | Injectable |
Route | Injection |
Strength | 1mg/ml |
Market Status | Prescription |
Company | Hospira; Teva Pharms Usa |
3 of 4 | |
---|---|
Drug Name | Marqibo kit |
Active Ingredient | Vincristine sulfate |
Dosage Form | Injectable, liposomal |
Route | Intravenous |
Strength | 5mg/5ml (1mg/ml) |
Market Status | Prescription |
Company | Talon Therap |
4 of 4 | |
---|---|
Drug Name | Vincristine sulfate pfs |
Active Ingredient | Vincristine sulfate |
Dosage Form | Injectable |
Route | Injection |
Strength | 1mg/ml |
Market Status | Prescription |
Company | Hospira; Teva Pharms Usa |
Antineoplastic Agents, Phytogenic
Agents obtained from higher plants that have demonstrable cytostatic or antineoplastic activity. (See all compounds classified as Antineoplastic Agents, Phytogenic.)
Tubulin Modulators
Agents that interact with TUBULIN to inhibit or promote polymerization of MICROTUBULES. (See all compounds classified as Tubulin Modulators.)
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
31
PharmaCompass offers a list of Vincristine Sulfate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Vincristine Sulfate manufacturer or Vincristine Sulfate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Vincristine Sulfate manufacturer or Vincristine Sulfate supplier.
PharmaCompass also assists you with knowing the Vincristine Sulfate API Price utilized in the formulation of products. Vincristine Sulfate API Price is not always fixed or binding as the Vincristine Sulfate Price is obtained through a variety of data sources. The Vincristine Sulfate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Oncovin (TN) manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Oncovin (TN), including repackagers and relabelers. The FDA regulates Oncovin (TN) manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Oncovin (TN) API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Oncovin (TN) manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Oncovin (TN) supplier is an individual or a company that provides Oncovin (TN) active pharmaceutical ingredient (API) or Oncovin (TN) finished formulations upon request. The Oncovin (TN) suppliers may include Oncovin (TN) API manufacturers, exporters, distributors and traders.
click here to find a list of Oncovin (TN) suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Oncovin (TN) DMF (Drug Master File) is a document detailing the whole manufacturing process of Oncovin (TN) active pharmaceutical ingredient (API) in detail. Different forms of Oncovin (TN) DMFs exist exist since differing nations have different regulations, such as Oncovin (TN) USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Oncovin (TN) DMF submitted to regulatory agencies in the US is known as a USDMF. Oncovin (TN) USDMF includes data on Oncovin (TN)'s chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Oncovin (TN) USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Oncovin (TN) suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Oncovin (TN) Drug Master File in Japan (Oncovin (TN) JDMF) empowers Oncovin (TN) API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Oncovin (TN) JDMF during the approval evaluation for pharmaceutical products. At the time of Oncovin (TN) JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Oncovin (TN) suppliers with JDMF on PharmaCompass.
A Oncovin (TN) CEP of the European Pharmacopoeia monograph is often referred to as a Oncovin (TN) Certificate of Suitability (COS). The purpose of a Oncovin (TN) CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Oncovin (TN) EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Oncovin (TN) to their clients by showing that a Oncovin (TN) CEP has been issued for it. The manufacturer submits a Oncovin (TN) CEP (COS) as part of the market authorization procedure, and it takes on the role of a Oncovin (TN) CEP holder for the record. Additionally, the data presented in the Oncovin (TN) CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Oncovin (TN) DMF.
A Oncovin (TN) CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Oncovin (TN) CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Oncovin (TN) suppliers with CEP (COS) on PharmaCompass.
A Oncovin (TN) written confirmation (Oncovin (TN) WC) is an official document issued by a regulatory agency to a Oncovin (TN) manufacturer, verifying that the manufacturing facility of a Oncovin (TN) active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Oncovin (TN) APIs or Oncovin (TN) finished pharmaceutical products to another nation, regulatory agencies frequently require a Oncovin (TN) WC (written confirmation) as part of the regulatory process.
click here to find a list of Oncovin (TN) suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Oncovin (TN) as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Oncovin (TN) API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Oncovin (TN) as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Oncovin (TN) and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Oncovin (TN) NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Oncovin (TN) suppliers with NDC on PharmaCompass.
Oncovin (TN) Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Oncovin (TN) GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Oncovin (TN) GMP manufacturer or Oncovin (TN) GMP API supplier for your needs.
A Oncovin (TN) CoA (Certificate of Analysis) is a formal document that attests to Oncovin (TN)'s compliance with Oncovin (TN) specifications and serves as a tool for batch-level quality control.
Oncovin (TN) CoA mostly includes findings from lab analyses of a specific batch. For each Oncovin (TN) CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Oncovin (TN) may be tested according to a variety of international standards, such as European Pharmacopoeia (Oncovin (TN) EP), Oncovin (TN) JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Oncovin (TN) USP).